HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Osmotics licenses anti-aging ingredient kinetin from Senetek for upscale skin care line.

This article was originally published in The Rose Sheet

Executive Summary

OSMOTICS SKIN CARE WITH SENETEK's ANTI-AGING KINETIN INGREDIENT will debut in the first quarter in prestige doors, including Saks Fifth Avenue, Neiman Marcus and Nordstrom, under a licensing agreement announced July 7. Osmotics will utilize Napa, Calif.-based Senetek's patented plant growth hormone to develop a "family of kinetin-based products" for the prestige skin care market. The line will include a transdermal patch, and may also contain items such as a serum, cream and lotion. The kinetin products also will roll out to Galeries Lafayette in Paris and Harrod's of London in the first quarter.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005628

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel